Hark ye, mateys! 'Tis good news fer scallywags with multiple ailments. No need to walk the plank just yet!
2024-04-19
Arrr mateys, the scurvy dogs be sayin' that there be no added peril for them with multiple sclerosis and cancer who be takin' the fancy checkpoint inhibitor therapy. A small study be suggestin' this, so ye can rest easy on the high seas! Aye aye, Medscape Medical News be bringin' the good tidings!
Arrr mateys, listen up! A small study has found that there be no extra risk of a relapse for them scallywags with multiple sclerosis and cancer who be takin' the checkpoint inhibitor therapy. Avast ye, this be good news for those brave souls fightin' off the scurvy dogs of disease!Ye see, this study, reported by Medscape Medical News, looked at the data and found no significant increase in the chance of a relapse for these patients. So, me hearties, ye can rest easy knowin' that the treatment ain't puttin' ye at any extra risk. So hoist the Jolly Roger and celebrate this victory!
So next time ye be talkin' to yer doctor about yer treatment plan, ye can mention this study and let them know that ye be worryin' about any extra risks. And remember, always be takin' care of yerself and listen to the advice of yer medical crew. Stay strong and keep fightin' the good fight, me fellow pirates!